Top

Published in:

01-02-2005

Multicenter Analysis of Clinicopathologic Features of Intraductal Papillary Mucinous Tumor of the Pancreas: Is It Possible to Predict the Malignancy Before Surgery?

Authors: Jin-Young Jang, MD, Sun-Whe Kim, MD, FACS, Young Joon Ahn, MD, Yoo-Seok Yoon, MD, Min Gew Choi, MD, Kuhn Uk Lee, MD, Joon Koo Han, MD, Woo Ho Kim, MD, Young Joo Lee, MD, Song Chul Kim, MD, Duck Jong Han, MD, Yong Il Kim, MD, Seong Ho Choi, MD, Baik Hwan Cho, MD, Hee Chul Yu, MD, Dong Sup Yoon, MD, Woo Jung Lee, MD, Kyung Bum Lee, MD, Young Chul Kim, MD, Kwang Soo Lee, MD, Myung-Wook Kim, MD, Hong Jin Kim, MD, Hyun Jong Kim, MD, Yong-Hyun Park, MD

Published in: Annals of Surgical Oncology | Issue 2/2005

Abstract

Background

Despite recently increasing numbers of reports on intraductal papillary mucinous tumors (IPMTs), difficulties still remain in terms of diagnosis, treatment, and prognosis. The purpose of this multicenter study was to evaluate the clinicopathologic features of IPMT in Korea and to suggest predictive criteria for malignancy in IPMT.

Methods

We retrospectively reviewed the clinicopathologic data of 208 patients who underwent operations for IPMT between 1993 and 2002 at 28 institutes in Korea.

Results

Of the 208 patients (mean age, 61 years), 147 were men and 61 were women. A total of 124 patients underwent pancreatoduodenectomy, 42 underwent distal pancreatectomy, 17 underwent total pancreatectomy, and 25 underwent limited pancreatic resection. There were 128 benign cases (adenoma, n = 62; borderline, n = 66) and 80 malignant cases (noninvasive, n = 29; invasive, n = 51). A significant difference in 5-year survival was observed between the benign and malignant groups (92.6% vs. 65.3%; P = .006). Of the six factors (age, location, duct dilatation, mural nodule, main duct type, and tumor size) that showed statistical differences by univariate analysis between the benign and malignant groups, three were significant by multivariate analysis—namely, mural nodule (P = .009), tumor size (P = .023), and a dilated duct size (P = .010).

Conclusions

A significant proportion of IPMTs are malignant, although the overall prognosis of IPMT is superior to that of ordinary pancreatic cancer. Radical surgery is recommended for IPMT with the predictors of malignancy: mural nodule, tumor size (⩾30 mm), and dilated duct size (⩾12 mm).

Ohhashi, K, Murakami, F, Murayama, M, et al. 1982Four cases of mucin-producing cancer of the pancreas on specific findings of the papilla of Vater (in Japanese)Prog Dig Endosc2034851

Sugiyama, M, Atomi, Y 1998Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategiesAnn Surg22868591PubMed

Yamaguchi, K, Tanaka, M 1991Mucin-hypersecreting tumor of the pancreas with mucin extrusion through an enlarged papillaAm J Gastroenterol868359PubMed

Obara, T, Maguchi, H, Saitoh, Y, et al. 1991Mucin-producing tumor of the pancreas: a unique clinical entityAm J Gastroenterol86161925PubMed

Sugiyama, M, Izumisato, Y, Abe, N, Masaki, T, Mori, T, Atomi, Y 2003Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreasBr J Surg9012449PubMed

McDonald, JM, Williard, W, Mais, D, Beitler, A 2000The incidence of intraductal papillary mucinous tumors of the pancreasCurr Surg576104PubMed

Nagai, E, Ueki, T, Chijiiwa, K, Tanaka, M, Tsuneyoshi, M 1995Intraductal papillary mucinous neoplasms of the pancreas associated with so-called “mucinous ductal ectasia.” Histochemical and immunohistochemical analysis of 29 casesAm J Surg Pathol1957689CrossRefPubMed

Azar, C, Stadt, J, Rickaert, F, et al. 1996Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patientsGut3945764PubMed

Traverso, LW, Peralta, EA, Ryan, JA,Jr, Kozarek, RA 1998Intraductal neoplasms of the pancreasAm J Surg17542632PubMed

10.

Cuillerier, E, Cellier, C, Palazzo, L, et al. 2000Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreasAm J Gastroenterol954415PubMed

11.

Hara, T, Yamaguchi, T, Ishihara, T, et al. 2002Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonographyGastroenterology1223443PubMed

12.

Wakabayashi, T, Kawaura, Y, Morimoto, H, et al. 2001Clinical management of intraductal papillary mucinous tumors of the pancreas based on imaging findingsPancreas223707PubMed

13.

Z’graggen, K, Rivera, JA, Compton, CC, et al. 1997Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreasAnn Surg2264918CrossRefPubMed

14.

Kondo, H, Sugano, K, Fukayama, N, et al. 1997Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreasCancer799005PubMed

15.

Kaino, M, Kondoh, S, Okita, S, et al. 1999Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumorsPancreas182949PubMed

16.

Biankin, AV, Biankin, SA, Kench, JG, et al. 2002Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinomaGut508618CrossRefPubMed

17.

Inoue, H, Tsuchida, A, Kawasaki, Y, Fujimoto, Y, Yamasaki, S, Kajiyama, G 2001Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activityCancer913541CrossRefPubMed

18.

Luttges, J, Feyerabend, B, Buchelt, T, Pacena, M, Kloppel, G 2002The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreasAm J Surg Pathol2646671PubMed

19.

Bernard, P, Scoazec, JY, Joubert, M, et al. 2002Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 casesArch Surg13712748PubMed

20.

Yamaguchi, K, Ogawa, Y, Chijiiwa, K, Tanaka, M 1996Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperativelyAm J Surg17142731PubMed

21.

Furukawa, T, Takahashi, T, Kobari, M, Matsuno, S 1992The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mappingCancer70150513PubMed

22.

Itoh, S, Ishiguchi, T, Ishigaki, T, Sakuma, S, Maruyama, K, Senda, K 1992Mucin-producing pancreatic tumor: CT findings and histopathologic correlationRadiology183816PubMed

23.

Obara, T, Maguchi, H, Saitoh, Y, et al. 1993Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changesAm J Gastroenterol885649PubMed

24.

Kobari, M, Egawa, S, Shibuya, K, et al. 1999Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical managementArch Surg13411316PubMed

25.

Kamisawa, T, Fujiwara, T, Tu, Y, et al. 2002Long-term follow-up of intraductal papillary adenoma of the pancreasJ Gastroenterol3786873PubMed

26.

Kanazumi, N, Nakao, A, Kaneko, T, et al. 2001Surgical treatment of intraductal papillary-mucinous tumors of the pancreasHepatogastroenterology4896771PubMed

27.

Chari, ST, Yadav, D, Smyrk, TC, et al. 2002Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreasGastroenterology12315007PubMed

28.

Sugiyama, M, Atomi, Y 1999Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreasAm J Gastroenterol944703PubMed

29.

Brat, DJ, Lillemoe, KD, Yeo, CJ, Warfield, PB, Hruban, RH 1998Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreasAm J Surg Pathol221639PubMed

30.

Yamaguchi, K, Ohuchida, J, Ohtsuka, T, Nakano, K, Tanaka, M 2002Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreasPancreatology248490PubMed

Title: Multicenter Analysis of Clinicopathologic Features of Intraductal Papillary Mucinous Tumor of the Pancreas: Is It Possible to Predict the Malignancy Before Surgery?
Authors: Jin-Young Jang, MD
Sun-Whe Kim, MD, FACS
Young Joon Ahn, MD
Yoo-Seok Yoon, MD
Min Gew Choi, MD
Kuhn Uk Lee, MD
Joon Koo Han, MD
Woo Ho Kim, MD
Young Joo Lee, MD
Song Chul Kim, MD
Duck Jong Han, MD
Yong Il Kim, MD
Seong Ho Choi, MD
Baik Hwan Cho, MD
Hee Chul Yu, MD
Dong Sup Yoon, MD
Woo Jung Lee, MD
Kyung Bum Lee, MD
Young Chul Kim, MD
Kwang Soo Lee, MD
Myung-Wook Kim, MD
Hong Jin Kim, MD
Hyun Jong Kim, MD
Yong-Hyun Park, MD
Publication date: 01-02-2005
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 2/2005
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/ASO.2005.02.030

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Multicenter Analysis of Clinicopathologic Features of Intraductal Papillary Mucinous Tumor of the Pancreas: Is It Possible to Predict the Malignancy Before Surgery?

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2005

The Results of Frozen Section, Touch Preparation, and Cytological Smear Are Comparable for Intraoperative Examination of Sentinel Lymph Nodes: A Study in 133 Breast Cancer Patients

Intraoperative Subareolar Injection of 99mTc-Labeled Sulfur Colloid Results in Consistent Sentinel Lymph Node Identification

It Is Still Not the Time to Change Surgical Strategy for Gastric Cancer

Rectus Flap Reconstruction Decreases Perineal Wound Complications After Pelvic Chemoradiation and Surgery: A Cohort Study

Popliteal Lymph Node Dissection

It Is Still Not the Time to Change Surgical Strategy for Gastric Cancer